Samsung Electronics has announced that it will acquire Xealth, a U.S.-based healthcare platform, to strengthen its presence in the digital healthcare sector. This move is part of the company’s larger plan to expand its mobile healthcare services business.
Xealth is a healthcare technology company that helps doctors and hospitals recommend and manage digital health tools for patients. These tools can include apps, services, and devices that help patients manage their health at home. Xealth works with many hospitals and health systems in the U.S. and is known for making it easier for patients to follow medical advice using their phones or computers.
Samsung is already known for its smart devices like Galaxy smartphones and smartwatches, which include health features like heart rate monitoring, step tracking, and sleep tracking. With this acquisition, Samsung wants to connect its health devices more closely with hospitals and doctors, making it easier for patients to manage their care using Samsung’s technology.
By bringing Xealth into its business, Samsung plans to make its health services more useful, trusted, and widely used — especially in the U.S. market, where digital health is growing rapidly.
Digital healthcare is becoming more important around the world. More people want to track their health at home and stay connected with doctors through mobile apps. Samsung sees this as a big opportunity to offer new services that combine its tech expertise with medical needs.
Read more: THIS Tobacco Stock Turned ₹1 Lakh Into ₹9 Lakhs in Just 5 Years!
Samsung’s decision to acquire Xealth shows how seriously it is taking its role in the future of healthcare. By combining Samsung’s mobile technology with Xealth’s healthcare platform, the company hopes to offer smarter, more connected, and patient-friendly healthcare solutions. As digital health continues to grow, Samsung aims to be a key player in helping people take better care of their health using technology.
Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.
Investments in the securities market are subject to market risks. Read all the related documents carefully before investing.
Published on: Jul 8, 2025, 1:48 PM IST
We're Live on WhatsApp! Join our channel for market insights & updates